|
1
|
Escobar-Morreale HF: Polycystic ovary
syndrome: Definition, aetiology, diagnosis and treatment. Nat Rev
Endocrinol. 14:270–284. 2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Neven ACH, Laven J, Teede HJ and Boyle JA:
A summary on polycystic ovary syndrome: Diagnostic criteria,
prevalence, clinical manifestations, and management according to
the latest international guidelines. Semin Reprod Med. 36:5–12.
2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Cai L, Ma X, Liu S, Liu J, Wang W, Cui Y,
Ding W, Mao Y, Chen H, Huang J, et al: Effects of upregulation of
Hsp27 expression on oocyte development and maturation derived from
polycystic ovary syndrome. PLoS One. 8(e83402)2013.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Shen H and Wang Y: Activation of
TGF-β1/Smad3 signaling pathway inhibits the development of ovarian
follicle in polycystic ovary syndrome by promoting apoptosis of
granulosa cells. J Cell Physiol. 234:11976–11985. 2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Yeung CK, Wang G, Yao Y, Liang J, Tenny
Chung CY, Chuai M, Lee KK and Yang X: BRE modulates granulosa cell
death to affect ovarian follicle development and atresia in the
mouse. Cell Death Dis. 8(e2697)2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Mikaeili S, Rashidi BH, Safa M, Najafi A,
Sobhani A, Asadi E and Abbasi M: Altered FoxO3 expression and
apoptosis in granulosa cells of women with polycystic ovary
syndrome. Arch Gynecol Obstet. 294:185–192. 2016.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Azhary JMK, Harada M, Takahashi N, Nose E,
Kunitomi C, Koike H, Hirata T, Hirota Y, Koga K, Wada-Hiraike O, et
al: Endoplasmic reticulum stress activated by androgen enhances
apoptosis of granulosa cells via induction of death receptor 5 in
PCOS. Endocrinology. 160:119–132. 2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Zheng Q, Li Y, Zhang D, Cui X, Dai K, Yang
Y, Liu S, Tan J and Yan Q: ANP promotes proliferation and inhibits
apoptosis of ovarian granulosa cells by NPRA/PGRMC1/EGFR complex
and improves ovary functions of PCOS rats. Cell Death Dis.
8(e3145)2017.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Zhao KK, Cui YG, Jiang YQ, Wang J, Li M,
Zhang Y, Ma X, Diao FY and Liu JY: Effect of HSP10 on apoptosis
induced by testosterone in cultured mouse ovarian granulosa cells.
Eur J Obstet Gynecol Reprod Biol. 171:301–306. 2013.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Pal I, Safari M, Jovanovic M, Bates SE and
Deng C: Targeting translation of mRNA as a therapeutic strategy in
cancer. Curr Hematol Malig Rep. 14:219–227. 2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Feng X, Xue H, Guo S, Chen Y, Zhang X and
Tang X: miR-874-3p suppresses cell proliferation and invasion by
targeting ADAM19 in nasopharyngeal carcinoma. Panminerva Med: Jul
19, 2019 (Epub ahead of print). doi:
10.23736/S0031-0808.19.03682-6.
|
|
12
|
Yuan RB, Zhang SH, He Y, Zhang XY and
Zhang YB: miR-874-3p is an independent prognostic factor and
functions as an anti-oncomir in esophageal squamous cell carcinoma
via targeting STAT3. Eur Rev Med Pharmacol Sci. 22:7265–7273.
2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Yan Y, Song X, Li Z, Zhang J, Ren J, Wu J,
Li Y, Guan Y and Wang J: Elevated levels of granzyme B correlated
with miR-874-3p downregulation in patients with acute myocardial
infarction. Biomark Med. 11:761–767. 2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Kushwaha P, Khedgikar V, Sharma D, Yuen T,
Gautam J, Ahmad N, Karvande A, Mishra PR, Trivedi PK, Sun L, et al:
MicroRNA 874-3p exerts skeletal anabolic effects epigenetically
during weaning by suppressing Hdac1 expression. J Biol Chem.
291:3959–3966. 2016.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Huo W and Li H, Zhang Y and Li H:
Epigenetic silencing of microRNA-874-3p implicates in erectile
dysfunction in diabetic rats by activating the Nupr1/Chop-mediated
pathway. FASEB J. 34:1695–1709. 2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Wang XQ, Bai HM, Li ST, Sun H, Min LZ, Tao
BB, Zhong J and Li B: Knockdown of HDAC1 expression suppresses
invasion and induces apoptosis in glioma cells. Oncotarget.
8:48027–48040. 2017.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Demyanenko SV, Dzreyan VA, Neginskaya MA
and Uzdensky AB: Expression of histone deacetylases HDAC1 and HDAC2
and their role in apoptosis in the penumbra induced by
photothrombotic stroke. Mol Neurobiol. 57:226–238. 2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Rotterdam ESHRE/ASRM-Sponsored PCOS
consensus workshop group. Revised 2003 consensus on diagnostic
criteria and long-term health risks related to polycystic ovary
syndrome (PCOS). Hum Reprod. 19:41–47. 2004.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Ferrero H, Delgado-Rosas F, Garcia-Pascual
CM, Monterde M, Zimmermann RC, Simón C, Pellicer A and Gómez R:
Efficiency and purity provided by the existing methods for the
isolation of luteinized granulosa cells: A comparative study. Hum
Reprod. 27:1781–1789. 2012.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Brooks CL and Gu W: The impact of
acetylation and deacetylation on the p53 pathway. Protein Cell.
2:456–462. 2011.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Chen B, Xu P, Wang J and Zhang C: The role
of miRNA in polycystic ovary syndrome (PCOS). Gene. 706:91–96.
2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Chen Z, Ou H, Wu H, Wu P and Mo Z: Role of
microRNA in the pathogenesis of polycystic ovary syndrome. DNA Cell
Biol. 38:754–762. 2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Wang P, Wang Z and Liu J: Role of HDACs in
normal and malignant hematopoiesis. Mol Cancer.
19(5)2020.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Seto E and Yoshida M: Erasers of histone
acetylation: The histone deacetylase enzymes. Cold Spring Harb
Perspect Biol. 6(a018713)2014.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Tao X, Zhang X, Ge SQ, Zhang EH and Zhang
B: Expression of SIRT1 in the ovaries of rats with polycystic ovary
syndrome before and after therapeutic intervention with exenatide.
Int J Clin Exp Pathol. 8:8276–8283. 2015.PubMed/NCBI
|
|
27
|
Isojarvi JI, Laatikainen TJ, Pakarinen AJ,
Juntunen KT and Myllyla VV: Polycystic ovaries and hyperandrogenism
in women taking valproate for epilepsy. N Engl J Med.
329:1383–1388. 1993.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Gaughan L, Logan IR, Cook S, Neal DE and
Robson CN: Tip60 and histone deacetylase 1 regulate androgen
receptor activity through changes to the acetylation status of the
receptor. J Biol Chem. 277:25904–25913. 2002.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Welsbie DS, Xu J, Chen Y, Borsu L, Scher
HI, Rosen N and Sawyers CL: Histone deacetylases are required for
androgen receptor function in hormone-sensitive and
castrate-resistant prostate cancer. Cancer Res. 69:958–966.
2009.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Ou HL and Schumacher B: DNA damage
responses and p53 in the aging process. Blood. 131:488–495.
2018.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Pronsato L and Milanesi L: Effect of
testosterone on the regulation of p53 and p66Shc during oxidative
stress damage in C2C12 cells. Steroids. 106:41–54. 2016.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Luo J, Su F, Chen D, Shiloh A and Gu W:
Deacetylation of p53 modulates its effect on cell growth and
apoptosis. Nature. 408:377–381. 2000.PubMed/NCBI View
Article : Google Scholar
|
|
33
|
Chen S, Yao X, Li Y, Saifudeen Z,
Bachvarov D and El-Dahr SS: Histone deacetylase 1 and 2 regulate
Wnt and p53 pathways in the ureteric bud epithelium. Development.
142:1180–1192. 2015.PubMed/NCBI View Article : Google Scholar
|
